immune thrombocytopenia Archives -

Patients across the UK with chronic immune thrombocytopenia (ITP) now have another treatment option, after NICE backed use

NICE says yes to Grifols’ Tavlesse for rare blood disorder ITP

https://pharmaphorum.com/news/nice-says-yes-to-grifols-tavlesse-for-rare-blood-disorder-itp/

Sweden’s Sobi has secured EU approval for Doptelet in primary chronic immune thrombocytopenia (ITP), an indication that the

Sobi gets EU nod for Doptelet in rare blood disorder ITP

https://pharmaphorum.com/news/sobi-gets-eu-nod-for-doptelet-in-rare-blood-disorder-itp/

The FDA has agreed to expedite development of two rare disease drugs from Sanofi. The most significant of

FDA to expedite development of two Sanofi rare disease drugs

https://pharmaphorum.com/news/fda-to-expedite-development-of-two-sanofi-rare-disease/

immune thrombocytopenia